A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases

NCT07583030 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE)
Relapsed/Refractory IgG4-Related Disease (r/r IgG4-RD)
Progressive Multiple Sclerosis (PMS)
Relapsed/Refractory Myasthenia Gravis(r/r MS)

Interventions

BIOLOGICAL: LVIVO-TaVec400 product

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Collaborators

[object Object]